Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Zhuo

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Journal of Fish Diseases|January 15, 2016
Identification and pathogenicity of Vibrio parahaemolyticus isolates and immune responses of Penaeus (Litopenaeus) vannamei (Boone)X P Hong, D Xu, Y Zhuo, et al.
Genetics and Molecular Research : GMR|September 9, 2015
Immune memory responses to HBV vaccine 13-18 years after primary vaccinationL Hou, W Li, X Wei, et al.
Fa Yi Xue Za Zhi|January 23, 2003
[Gas chromatography with dual nitrogen-phosphorus detection and flame ionization detection for screening abuse drugs]Y J Sun, M T Wu, X Y Zhuo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Comparative study of three common G6PD gene mutations in Yao and Han People in Guangxi]J Liu, X Ren, Q Chen, et al.
Bone|July 20, 2014
Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversibleY Zhuo, J-Y Gauthier, W C Black, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 1, 2002
[Effects of p21WAF1/CIP1 gene introduction on a human lung cancer cell line with p53 mutation]Y Zhuo, B Zhang, T Li, et al.
Yan Ke Xue Bao = Eye Science|February 13, 2003
New management of angle-closure glaucoma by phacoemulsification with foldable posterior chamber intraocular lens implantationJ Ge, Y Guo, Y Liu, et al.
Fa Yi Xue Za Zhi|February 15, 2018
[Identification of Methamphetamine Abuse and Selegiline Use: Chiral Analysis of Methamphetamine and Amphetamine in Urine]P Xiang, J Bu, Z Qiao, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphomaY Q Wang, Y Yang, H Y Zhuo, et al.
Journal of Medical Economics|April 30, 2014
A cost-analysis model for anticoagulant treatment in the hospital settingSamir H Mody, Lynn Huynh, Daisy Y Zhuo, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Journal of Fish Diseases|January 15, 2016
Identification and pathogenicity of Vibrio parahaemolyticus isolates and immune responses of Penaeus (Litopenaeus) vannamei (Boone)X P Hong, D Xu, Y Zhuo, et al.
Genetics and Molecular Research : GMR|September 9, 2015
Immune memory responses to HBV vaccine 13-18 years after primary vaccinationL Hou, W Li, X Wei, et al.
Fa Yi Xue Za Zhi|January 23, 2003
[Gas chromatography with dual nitrogen-phosphorus detection and flame ionization detection for screening abuse drugs]Y J Sun, M T Wu, X Y Zhuo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Comparative study of three common G6PD gene mutations in Yao and Han People in Guangxi]J Liu, X Ren, Q Chen, et al.
Bone|July 20, 2014
Inhibition of bone resorption by the cathepsin K inhibitor odanacatib is fully reversibleY Zhuo, J-Y Gauthier, W C Black, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|March 1, 2002
[Effects of p21WAF1/CIP1 gene introduction on a human lung cancer cell line with p53 mutation]Y Zhuo, B Zhang, T Li, et al.
Yan Ke Xue Bao = Eye Science|February 13, 2003
New management of angle-closure glaucoma by phacoemulsification with foldable posterior chamber intraocular lens implantationJ Ge, Y Guo, Y Liu, et al.
Fa Yi Xue Za Zhi|February 15, 2018
[Identification of Methamphetamine Abuse and Selegiline Use: Chiral Analysis of Methamphetamine and Amphetamine in Urine]P Xiang, J Bu, Z Qiao, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Trial of LVDP regimen (L-asparaginase, etoposide, dexamethasone, and cisplatin, followed by radiotherapy) as first-line treatment for newly diagnosed, stage III/IV extranodal natural killer/T cell lymphomaY Q Wang, Y Yang, H Y Zhuo, et al.
Journal of Medical Economics|April 30, 2014
A cost-analysis model for anticoagulant treatment in the hospital settingSamir H Mody, Lynn Huynh, Daisy Y Zhuo, et al.
Pageof 8